H.C. Wainwright raised the firm’s price target on ChromaDex (CDXC) to $8 from $6 and keeps a Buy rating on the shares post the Q3 report. The company reported slight sales outperformance and solid earnings beat with “multiple potential tailwinds,” the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXC: